search
Back to results

Inspiratory Muscle Training in Acute Decompensated Heart Failure

Primary Purpose

Acute Decompensated Heart Failure

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
inspiratory muscle training device
Physical training
Sponsored by
Dokuz Eylul University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Acute Decompensated Heart Failure

Eligibility Criteria

45 Years - 85 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • The management of a diagnosis of ADHF over 24 hours in a hospital setting
  • Hemodynamic stability
  • The independence of basic activities of daily life before admission

Exclusion Criteria:

  • Acute myocardial infarction
  • Congenital heart disease
  • Endocarditis, miyocarditis or pericarditis
  • Morbid obesity
  • Already participating in cardiac rehabilitation

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Active Comparator

    Arm Label

    Physical training plus inspiratory muscle training

    Physical training

    Arm Description

    Inspiratory Muscle Training (IMT) will be implemented by using the Power Breathe® device. IMT training will begin with mild to moderate intensity of maximal inspiratory pressure. It will be performed 6 to 10 breaths, 4 sets, and twice daily during the hospitalization when as soon as hemodynamic stability is provided. Physical Training will consist of each functional domain (balance, mobility, strength, and endurance) according to patients' functional levels. These will include static and dynamic balance training, mobility training, functional strength training focused on lower extremities, and endurance training as sustained walking. A daily 30 min session during the hospitalization will be performed with one-on-one supervision when as soon as hemodynamic stability is provided.

    Physical Training will consist of each functional domain (balance, mobility, strength, and endurance) according to patients' functional levels. These will include static and dynamic balance training, mobility training, functional strength training focused on lower extremities, and endurance training as sustained walking. A daily 30 min session during the hospitalization will be performed with one-on-one supervision when as soon as hemodynamic stability is provided.

    Outcomes

    Primary Outcome Measures

    Maximal Inspiratory Pressure
    Maximal inspiratory pressure will be measured by an electronic mouth pressure device (cmH2O)

    Secondary Outcome Measures

    Adverse events
    The number of adverse events resulting from the intervention will be noted. Adverse events include blood pressure greater than 170/100 mmHg, desaturation of oxygen greater than 4%, severe musculoskeletal and/or chest pain, dyspnea greater than 6 on the Borg scale, dizziness, nausea, vomiting, bleeding, loss or obstruction of the central or peripheral catheter.
    Recruitment rate
    The number of participants divided by the total number of eligible patients (%)
    Adherence rate
    The number of training sessions divided by the total number of potential sessions (%)
    Retention rate
    The number of patients who complete the protocol divided by the total number of patients included in the study (%)
    New York Heart Association Functional Classification
    Functional Classification will be assessed with New York Heart Association (NYHA) Functional Classification. The minimum value is 1 whereas the maximum value is 4. Higher scores indicate the lower functional class.
    Dyspnea
    Dyspnea will be assessed by using the Modified Medical Research Council Scale. It is a 5-item scale. Higher scores indicate higher dyspnea perception.
    Hand Grip Strength
    Hand grip strength will be measured by a dynamometer.
    Physical Performance
    Physical performance will be measured by Short Physical Performance Battery (SPPB). SPPB comprises 5 times sit-to-stand, standing balance and 4-m gait speed. The total score ranges from 0 to 12 and a higher score indicates better physical performance.
    Frailty
    Frailty will be assessed by using the Clinical Frailty Scale (CFS). CFS scores on a scale from 1 (very fit) to 9 (terminally ill).
    Cardiac autonomic function
    Cardiac autonomic function will be evaluated with heart rate variability analysis by using a SphygmoCor ® device.
    Arterial Stiffness
    Arterial stiffness will be measured by augmentation index using a SphygmoCor® device.
    Disability
    Disability will be assessed by using Barthel Index. It occurs 10 questions and the score ranges from 0 to 100. Higher scores indicate greater independence.
    One-year mortality
    The mortality rate during the first year following hospital discharge

    Full Information

    First Posted
    April 1, 2021
    Last Updated
    October 30, 2022
    Sponsor
    Dokuz Eylul University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04834336
    Brief Title
    Inspiratory Muscle Training in Acute Decompensated Heart Failure
    Official Title
    Effects of Inspiratory Muscle Training in Patients With Acute Decompensated Heart Failure
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    October 2022
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    January 15, 2023 (Anticipated)
    Primary Completion Date
    April 1, 2023 (Anticipated)
    Study Completion Date
    April 1, 2024 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Dokuz Eylul University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No

    5. Study Description

    Brief Summary
    Hospitalized patients with acute decompensated heart failure (ADHF) present a high prevalence of inspiratory muscle weakness on admission and discharge. Inspiratory muscle training has been reported as a beneficial approach in chronic heart failure. However, the effects of inspiratory muscle training in hospitalized patients with ADHF have been not known. The aim of this study is to investigate the safety, feasibility, and effects of inspiratory muscle training in hospitalized patients with ADHF.
    Detailed Description
    The participants will randomly be allocated into two groups: (1) Physical training plus inspiratory muscle training, (2) Physical training Participants in the physical training plus inspiratory muscle training group will perform inspiratory muscle training and physical training. Inspiratory muscle training will be applied with an electronic device. Physical training will be implemented as balance, mobility, functional strength, endurance exercises. During the hospitalization, the inspiratory muscle training will be carried out twice a day with mild to moderate whereas physical training will be carried out once a day. The physical training group will perform only physical training. Physical training will be implemented as balance, mobility, functional strength, endurance exercises. During the hospitalization, physical training will be carried out once a day. For the safety and feasibility of inspiratory muscle training, data will be collected daily during the hospitalization. For effects of inspiratory muscle training, data will be collected at baseline and hospital discharge.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Acute Decompensated Heart Failure

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    Participant
    Allocation
    Randomized
    Enrollment
    28 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Physical training plus inspiratory muscle training
    Arm Type
    Experimental
    Arm Description
    Inspiratory Muscle Training (IMT) will be implemented by using the Power Breathe® device. IMT training will begin with mild to moderate intensity of maximal inspiratory pressure. It will be performed 6 to 10 breaths, 4 sets, and twice daily during the hospitalization when as soon as hemodynamic stability is provided. Physical Training will consist of each functional domain (balance, mobility, strength, and endurance) according to patients' functional levels. These will include static and dynamic balance training, mobility training, functional strength training focused on lower extremities, and endurance training as sustained walking. A daily 30 min session during the hospitalization will be performed with one-on-one supervision when as soon as hemodynamic stability is provided.
    Arm Title
    Physical training
    Arm Type
    Active Comparator
    Arm Description
    Physical Training will consist of each functional domain (balance, mobility, strength, and endurance) according to patients' functional levels. These will include static and dynamic balance training, mobility training, functional strength training focused on lower extremities, and endurance training as sustained walking. A daily 30 min session during the hospitalization will be performed with one-on-one supervision when as soon as hemodynamic stability is provided.
    Intervention Type
    Device
    Intervention Name(s)
    inspiratory muscle training device
    Intervention Description
    Inspiratory muscle training will be performed with an inspiratory muscle training device.
    Intervention Type
    Other
    Intervention Name(s)
    Physical training
    Intervention Description
    Physical training will be performed with exercise including balance, mobility, functional strength, and endurance.
    Primary Outcome Measure Information:
    Title
    Maximal Inspiratory Pressure
    Description
    Maximal inspiratory pressure will be measured by an electronic mouth pressure device (cmH2O)
    Time Frame
    baseline and hospital discharge, an average of 4 to 10 days
    Secondary Outcome Measure Information:
    Title
    Adverse events
    Description
    The number of adverse events resulting from the intervention will be noted. Adverse events include blood pressure greater than 170/100 mmHg, desaturation of oxygen greater than 4%, severe musculoskeletal and/or chest pain, dyspnea greater than 6 on the Borg scale, dizziness, nausea, vomiting, bleeding, loss or obstruction of the central or peripheral catheter.
    Time Frame
    During the hospitalization, daily, during an average of 4 to 10 days
    Title
    Recruitment rate
    Description
    The number of participants divided by the total number of eligible patients (%)
    Time Frame
    During the hospitalization, daily, during an average of 4 to 10 days
    Title
    Adherence rate
    Description
    The number of training sessions divided by the total number of potential sessions (%)
    Time Frame
    During the hospitalization, daily, during an average of 4 to 10 days
    Title
    Retention rate
    Description
    The number of patients who complete the protocol divided by the total number of patients included in the study (%)
    Time Frame
    During the hospitalization, daily, during an average of 4 to 10 days
    Title
    New York Heart Association Functional Classification
    Description
    Functional Classification will be assessed with New York Heart Association (NYHA) Functional Classification. The minimum value is 1 whereas the maximum value is 4. Higher scores indicate the lower functional class.
    Time Frame
    baseline and hospital discharge, an average of 4 to 10 days
    Title
    Dyspnea
    Description
    Dyspnea will be assessed by using the Modified Medical Research Council Scale. It is a 5-item scale. Higher scores indicate higher dyspnea perception.
    Time Frame
    baseline and hospital discharge, an average of 4 to 10 days
    Title
    Hand Grip Strength
    Description
    Hand grip strength will be measured by a dynamometer.
    Time Frame
    baseline and hospital discharge, an average of 4 to 10 days
    Title
    Physical Performance
    Description
    Physical performance will be measured by Short Physical Performance Battery (SPPB). SPPB comprises 5 times sit-to-stand, standing balance and 4-m gait speed. The total score ranges from 0 to 12 and a higher score indicates better physical performance.
    Time Frame
    baseline and hospital discharge, an average of 4 to 10 days
    Title
    Frailty
    Description
    Frailty will be assessed by using the Clinical Frailty Scale (CFS). CFS scores on a scale from 1 (very fit) to 9 (terminally ill).
    Time Frame
    baseline and hospital discharge, an average of 4 to 10 days
    Title
    Cardiac autonomic function
    Description
    Cardiac autonomic function will be evaluated with heart rate variability analysis by using a SphygmoCor ® device.
    Time Frame
    baseline and hospital discharge, an average of 4 to 10 days
    Title
    Arterial Stiffness
    Description
    Arterial stiffness will be measured by augmentation index using a SphygmoCor® device.
    Time Frame
    baseline and hospital discharge, an average of 4 to 10 days
    Title
    Disability
    Description
    Disability will be assessed by using Barthel Index. It occurs 10 questions and the score ranges from 0 to 100. Higher scores indicate greater independence.
    Time Frame
    baseline and hospital discharge, an average of 4 to 10 days
    Title
    One-year mortality
    Description
    The mortality rate during the first year following hospital discharge
    Time Frame
    one year after discharge

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    45 Years
    Maximum Age & Unit of Time
    85 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: The management of a diagnosis of ADHF over 24 hours in a hospital setting Hemodynamic stability The independence of basic activities of daily life before admission Exclusion Criteria: Acute myocardial infarction Congenital heart disease Endocarditis, miyocarditis or pericarditis Morbid obesity Already participating in cardiac rehabilitation
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Aylin Tanriverdi
    Phone
    +905352359989
    Email
    tanrverdiaylin@gmail.com
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Sema Savci, Prof
    Organizational Affiliation
    Dokuz Eylul University
    Official's Role
    Study Director

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    Inspiratory Muscle Training in Acute Decompensated Heart Failure

    We'll reach out to this number within 24 hrs